Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.270
-0.100 (-2.29%)
At close: May 27, 2026, 4:00 PM EDT
4.290
+0.020 (0.47%)
After-hours: May 27, 2026, 7:01 PM EDT

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $3.27M in the quarter ending March 31, 2026, a decrease of -45.11%. This brings the company's revenue in the last twelve months to $28.22M, up 20.08% year-over-year. In the year 2025, Foghorn Therapeutics had annual revenue of $30.91M with 36.75% growth.

Revenue (ttm)
$28.22M
Revenue Growth
+20.08%
P/S Ratio
8.88
Revenue / Employee
$266,264
Employees
106
Market Cap
250.71M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M8.31M36.75%
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Coherus Oncology46.88M
Orchestra BioMed Holdings32.72M
LENZ Therapeutics20.99M
Sol-Gel Technologies19.39M
Alector18.42M
Adagene7.67M
Entrada Therapeutics5.74M
Camp4 Therapeutics3.93M
Revenue Rankings

FHTX News

More News